SenesTech ships rodent control product to Midwest firm

Published 18/02/2025, 14:50
SenesTech ships rodent control product to Midwest firm

PHOENIX, Ariz. - SenesTech, Inc. (NASDAQ: SNES), a $3.52 million market cap company known for its advancements in rodent pest control, has recently begun shipping its Evolve™ Rodent Birth Control product to a major warehousing and distribution company in the Midwest. The transaction signifies the company’s first foray into the warehousing and distribution sector, coming at a time when the stock has shown strong momentum with a ~13% gain over the past week. The customer plans to both use the product in their facilities and distribute it through their network.

The warehousing industry, crucial to the supply chain in the United States, spans over 18 billion square feet of space, creating a significant market for pest control solutions. SenesTech’s strategic move to enter this sector with Evolve Rodent Birth Control is aimed at addressing the unique challenges of managing rodent populations in environments where traditional poisons are not suitable, particularly in areas storing food supplies. According to InvestingPro data, the company has demonstrated strong growth potential with a 38% year-over-year revenue increase and maintains a healthy gross profit margin of 50%.

Joel Fruendt, President and CEO of SenesTech, emphasized the importance of a humane and effective alternative to poisons, noting that Evolve Rodent Birth Control is designed to ensure the safety of stored products while complying with industry regulations.

SenesTech’s mission focuses on creating healthier environments by managing animal pest populations through fertility control. Their products, including Evolve™, are designed to be integrated into existing pest management programs, enhancing their effectiveness and reducing the reliance on traditional poisons.

The company’s expansion into new markets is part of a broader strategic initiative to offer innovative, non-lethal rodent control solutions to industries facing challenges with conventional methods.

The information in this article is based on a press release statement.

In other recent news, SenesTech, Inc. has expanded its digital footprint by making its Evolve™ Rodent Birth Control product available on TractorSupply.com. This move aligns with the company’s strategy to increase its e-commerce reach and offer a wider national customer base a non-toxic solution for rodent control. SenesTech’s President and CEO, Joel Fruendt, has highlighted this expansion as a significant step in enhancing online distribution and meeting the growing consumer demand for sustainable and humane rodent control options.

In another development, H.C. Wainwright has upgraded its price target for SenesTech, maintaining a Buy rating due to the company’s robust financial performance. The company has shown consistent sequential revenue growth, improved gross profits, and reduced operating costs. SenesTech’s Evolve formulation for rats has become its best-selling product, contributing to over half of its total revenues. The analyst firm anticipates over 100% revenue growth in 2025, supported by expanding international sales and increasing traction with municipalities and online retail platforms.

These are some of the recent developments that have shaped SenesTech’s current business landscape.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.